-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VSRemWl2CSQ3uH6yx/L227X4EI1wh4esRxe3I4BgpNED15i79GUPXBvxDF3+OzhF HVFhxD/xeQvLYp353yyf6g== 0000950131-99-000801.txt : 19990212 0000950131-99-000801.hdr.sgml : 19990212 ACCESSION NUMBER: 0000950131-99-000801 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990211 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: OPHIDIAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872947 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 391661164 STATE OF INCORPORATION: WI FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-55419 FILM NUMBER: 99530002 BUSINESS ADDRESS: STREET 1: 5445 E CHERYL PKWY CITY: MADISON STATE: WI ZIP: 53711 BUSINESS PHONE: 6082710878 MAIL ADDRESS: STREET 1: OPHIDIAN PHARMACEUTICALS INC STREET 2: 5445 EAST CHERYL PARKWAY CITY: MADISON STATE: WI ZIP: 53711 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LILLY ELI & CO CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 SC 13G 1 SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Ophidian Pharmaceuticals, Inc. ------------------------------ (Name of Issuer) Common Stock, $.0025 Par Value ------------------------------ (Title of Class of Securities) 683725105 --------- (CUSIP Number) N/A --- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ___ Rule 13d-1(b) ___ Rule 13d-1(c) X Rule 13d-1(d) --- *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 Pages CUSIP No. 683725105 (1) Name of Reporting Person: Eli Lilly and Company I.R.S. Identification 35-0470950 No. of Above Person (2) Check the Appropriate Box (a) [_] if a Member of a Group (b) [_] Not Applicable (3) SEC Use Only (4) Citizenship or Place of Indiana Organization Number of Shares (5) Sole Voting 699,300 Beneficially Owned Power by Each Reporting (6) Shared Voting None Person With Power (7) Sole Dispositive 699,300 Power (8) Shared Disposi- None tive Power (9) Aggregate Amount Beneficially 699,300 Owned by Each Reporting Person (10) Check if the Aggregate Amount Not Applicable In Row (9) Excludes Certain Shares (11) Percent of Class Represented 7.6% by Amount in Row (9) (12) Type of Reporting Person CO Page 2 of 5 Pages Item 1(a). Name of Issuer: Ophidian Pharmaceuticals, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 5445 East Cheryl Parkway Madison, WI 53711 Item 2(a). Name of Person Filing: Eli Lilly and Company Item 2(b). Address of Principal Business Office or, if None, Residence: Lilly Corporate Center Indianapolis, IN 46285 Item 2(c). Citizenship: Indiana Item 2(d). Title of Class of Securities: Common Stock, $.0025 Par Value Item 2(e). CUSIP Number: 683725105 Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: (a)-(j) Not applicable If this statement is filed pursuant to Rule 13d-1(c), check this box. [_] Page 3 of 5 Pages Item 4. Ownership. (a) Amount Beneficially Owned: 699,300 (b) Percent of Class: 7.6% (c) Number of shares as to which the person has: Sole voting power 699,300 Shared voting power None Sole dispositive power 699,300 Shared dispositive power None Item 5. Ownership of Five Percent or Less of a Class. Not applicable Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not applicable Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable Item 8. Identification and Classification of Members of the Group. Not applicable Item 9. Notice of Dissolution of Group. Not applicable Page 4 of 5 Pages Item 10. Certifications. Not applicable. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. ELI LILLY AND COMPANY By: /s/ Charles E. Golden --------------------------------------- Charles E. Golden Executive Vice President and Chief Financial Officer Date: February 11, 1999 Page 5 of 5 Pages -----END PRIVACY-ENHANCED MESSAGE-----